Expanding applications

In 2017, we launched SOZO®, the world’s most advanced BIS device. The FDA-cleared, CE-marked and ARTG-listed digital health platform aids in the early detection of secondary lymphedema, provides fluid status for patients living with heart failure and allows measurement and tracking of various body composition parameters.

We are currently exploring the use of our advanced bioimpedance technology for a wide range of commercial applications, including:

General health and weight management
Bone content
Protein-calorie malnutrition

ImpediMed Inc. Downloads

ImpediVET - Brochure

ImpediMed - Model SFB7 - Single-channel, Tetrapolar Bioimpedance Spectroscopy (BIS) Device - Brochure

SOZO - Digital Health Platform Brochure